CN114369808B - Method for preparing antibacterial coating on surface of magnesium and magnesium alloy - Google Patents
Method for preparing antibacterial coating on surface of magnesium and magnesium alloy Download PDFInfo
- Publication number
- CN114369808B CN114369808B CN202111563708.4A CN202111563708A CN114369808B CN 114369808 B CN114369808 B CN 114369808B CN 202111563708 A CN202111563708 A CN 202111563708A CN 114369808 B CN114369808 B CN 114369808B
- Authority
- CN
- China
- Prior art keywords
- magnesium
- magnesium alloy
- alloy
- copper
- layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000011777 magnesium Substances 0.000 title claims abstract description 76
- 229910000861 Mg alloy Inorganic materials 0.000 title claims abstract description 61
- 229910052749 magnesium Inorganic materials 0.000 title claims abstract description 58
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 title claims abstract description 52
- 238000000576 coating method Methods 0.000 title claims abstract description 36
- 239000011248 coating agent Substances 0.000 title claims abstract description 34
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 29
- 238000000034 method Methods 0.000 title claims abstract description 29
- 239000010949 copper Substances 0.000 claims abstract description 103
- 229910052802 copper Inorganic materials 0.000 claims abstract description 68
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 65
- 238000009792 diffusion process Methods 0.000 claims abstract description 51
- 230000008595 infiltration Effects 0.000 claims abstract description 29
- 238000001764 infiltration Methods 0.000 claims abstract description 29
- 239000011159 matrix material Substances 0.000 claims abstract description 29
- 238000007747 plating Methods 0.000 claims abstract description 28
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims abstract description 16
- 230000002829 reductive effect Effects 0.000 claims abstract description 9
- 229910052786 argon Inorganic materials 0.000 claims abstract description 8
- 238000002360 preparation method Methods 0.000 claims abstract description 8
- 239000000758 substrate Substances 0.000 claims abstract description 7
- 230000008021 deposition Effects 0.000 claims description 18
- 229910001278 Sr alloy Inorganic materials 0.000 claims description 7
- 229910001093 Zr alloy Inorganic materials 0.000 claims description 6
- 239000012535 impurity Substances 0.000 claims description 5
- 229910001279 Dy alloy Inorganic materials 0.000 claims description 2
- 229910000748 Gd alloy Inorganic materials 0.000 claims description 2
- 230000000149 penetrating effect Effects 0.000 claims description 2
- 208000015181 infectious disease Diseases 0.000 abstract description 30
- 150000002500 ions Chemical class 0.000 abstract description 15
- 238000011282 treatment Methods 0.000 abstract description 10
- 206010067268 Post procedural infection Diseases 0.000 abstract description 7
- 230000003111 delayed effect Effects 0.000 abstract description 6
- 239000010410 layer Substances 0.000 description 54
- 229910045601 alloy Inorganic materials 0.000 description 21
- 239000000956 alloy Substances 0.000 description 21
- 238000000151 deposition Methods 0.000 description 16
- 239000000243 solution Substances 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 11
- 231100000135 cytotoxicity Toxicity 0.000 description 11
- 230000003013 cytotoxicity Effects 0.000 description 11
- 239000000463 material Substances 0.000 description 11
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 9
- 229910001431 copper ion Inorganic materials 0.000 description 9
- 230000007797 corrosion Effects 0.000 description 9
- 238000005260 corrosion Methods 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 238000010849 ion bombardment Methods 0.000 description 9
- 239000007943 implant Substances 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 230000007423 decrease Effects 0.000 description 7
- 238000006731 degradation reaction Methods 0.000 description 7
- 230000000399 orthopedic effect Effects 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000002513 implantation Methods 0.000 description 6
- 238000002791 soaking Methods 0.000 description 6
- 230000015556 catabolic process Effects 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 239000012981 Hank's balanced salt solution Substances 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000005275 alloying Methods 0.000 description 4
- 238000002386 leaching Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000002980 postoperative effect Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000004544 sputter deposition Methods 0.000 description 4
- 208000035143 Bacterial infection Diseases 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 244000137852 Petrea volubilis Species 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 208000022362 bacterial infectious disease Diseases 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000002147 killing effect Effects 0.000 description 3
- 238000011056 performance test Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 229910000881 Cu alloy Inorganic materials 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- OWXLRKWPEIAGAT-UHFFFAOYSA-N [Mg].[Cu] Chemical compound [Mg].[Cu] OWXLRKWPEIAGAT-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 231100000263 cytotoxicity test Toxicity 0.000 description 2
- 238000001804 debridement Methods 0.000 description 2
- 230000001627 detrimental effect Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 238000005498 polishing Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000004528 spin coating Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004381 surface treatment Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 239000013077 target material Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 238000010146 3D printing Methods 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 239000005749 Copper compound Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241000588915 Klebsiella aerogenes Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000008952 bacterial invasion Effects 0.000 description 1
- 239000005313 bioactive glass Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 150000001880 copper compounds Chemical class 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 229940092559 enterobacter aerogenes Drugs 0.000 description 1
- 229940023064 escherichia coli Drugs 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 238000010335 hydrothermal treatment Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- SYJBLFMEUQWNFD-UHFFFAOYSA-N magnesium strontium Chemical compound [Mg].[Sr] SYJBLFMEUQWNFD-UHFFFAOYSA-N 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C14/00—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material
- C23C14/22—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material characterised by the process of coating
- C23C14/48—Ion implantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/04—Metals or alloys
- A61L27/047—Other specific metals or alloys not covered by A61L27/042 - A61L27/045 or A61L27/06
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/30—Inorganic materials
- A61L27/306—Other specific inorganic materials not covered by A61L27/303 - A61L27/32
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C14/00—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material
- C23C14/06—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material characterised by the coating material
- C23C14/14—Metallic material, boron or silicon
- C23C14/16—Metallic material, boron or silicon on metallic substrates or on substrates of boron or silicon
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C14/00—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material
- C23C14/22—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material characterised by the process of coating
- C23C14/54—Controlling or regulating the coating process
- C23C14/542—Controlling the film thickness or evaporation rate
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C14/00—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material
- C23C14/22—Coating by vacuum evaporation, by sputtering or by ion implantation of the coating forming material characterised by the process of coating
- C23C14/54—Controlling or regulating the coating process
- C23C14/548—Controlling the composition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2420/00—Materials or methods for coatings medical devices
- A61L2420/02—Methods for coating medical devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Metallurgy (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Materials Engineering (AREA)
- Mechanical Engineering (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Physical Vapour Deposition (AREA)
- Materials For Medical Uses (AREA)
Abstract
The invention discloses a method for preparing an antibacterial coating on the surface of magnesium and magnesium alloy, which is characterized by comprising the following preparation steps: mounting a copper target at a target position of double-layer glow plasma infiltration plating equipment, fixing a magnesium/magnesium alloy substrate on a sample table of the double-layer glow plasma infiltration plating equipment, arranging the copper target in parallel relative to the magnesium/magnesium alloy substrate, and performing infiltration plating to obtain an infiltration plating layer; the specific diffusion coating parameters are controlled as follows: the source voltage of the copper target is 600-700V, the working voltage of the magnesium/magnesium alloy matrix is 400-450V, the distance between the copper target and the magnesium/magnesium alloy matrix is 8-15 mm, the argon pressure is 20-45 Pa, and the infiltration plating time is 3-5 h. The diffusion coating realizes gradient release of Cu ions by utilizing different Cu ion concentrations of each layer, and performs strong antibacterial treatment aiming at early infection with strong postoperative infection degree by releasing high-concentration Cu ions; cu ions with continuously reduced concentration are released for the delayed infection with continuously weakened infection degree, and weak antibacterial treatment is carried out, so that the release of Cu ions and the antibacterial function are dynamically matched.
Description
Technical Field
The invention belongs to the technical field of metal material surface coatings, and particularly relates to a method for preparing an antibacterial coating on the surfaces of magnesium and magnesium alloy.
Background
Postoperative infection is one of the most serious and complex complications in orthopedic surgery, and causes great threat to wound healing and even life of patients, and is always highly valued by clinicians and related medical staff. Among them, infection caused by invasion of pathogenic bacteria into bone tissue during implantation of the orthopedic implant material is one of the main causes of infection after orthopedics. Infection in orthopedic artificial implantation surgery is classified into early infection and late infection. Early infection mainly is that when the operation incision exposes the operation field, operations such as cutting, pulling, separating, implanting and the like lead to external bacteria to invade the incision, so that the postoperative infection risk is increased, and the infection risk is generally maximum and the infection degree is stronger when the operation is continued for about one month after the operation. The delayed infection is caused by the decrease of the physique of individuals after operation of patients, and generally occurs 2-3 months after operation, and the infection degree is weaker.
At present, in order to avoid the occurrence of orthopedic operation infection clinically, two methods of preoperative prevention and postoperative treatment are mainly adopted. The preoperative method for preventing infection mainly comprises keeping the surrounding environment clean during operation, strictly sterilizing surgical instruments and implants, shortening the operation time, and the like, and the postoperative treatment mainly adopts surgical operations such as antibiotic therapy, debridement, and the like. However, these conventional therapies are inefficient, preoperative prophylaxis does not completely avoid bacterial invasion, and post-operative treatment can cause pain to the patient, bacteria can also develop resistance to antibiotics, so that bacteria are insensitive to antibiotics, and debridement operations cannot completely remove bacteria. Therefore, the ideal method for avoiding infection is to optimally design the implant material to have the capability of resisting bacterial infection, and can dynamically kill bacteria at different stages of the implantation period according to different infection degrees without the need of subsequent postoperative anti-infection treatment.
The magnesium alloy is a novel biodegradable (absorbable) bone implant material with great clinical application prospect due to the characteristics of good biocompatibility, mechanical property matched with bone tissue, capability of being degraded and absorbed in human body and the like. Although the magnesium alloy has good application prospect in the field of orthopedic implantation as a biological material, the magnesium alloy is also easy to cause infection in the degradation process. Therefore, when the degradable magnesium alloy is used as an orthopedic implant material for functional design, the antibacterial function is taken as one of the considerations, the magnesium alloy is expected to have the capability of resisting bacterial infection, can kill common bacteria in orthopaedics, avoid the occurrence of postoperative infection of orthopaedics, and provide a good action environment for the subsequent osteogenesis and vascularization functions of the magnesium alloy implant. Research shows that the high alkaline environment generated by the degradation of magnesium alloy in body fluid can destroy the living condition of bacteria and inhibit the growth and propagation of bacteria, thereby playing a role in killing bacteria. However, in a complex internal environment of the human body, the body fluid buffer effect weakens the alkaline environment generated by the degradation of the magnesium alloy, resulting in weakening or disappearance of the antibacterial effect depending on the alkaline environment alone. Therefore, more research is being conducted to address this problem, and long-lasting antimicrobial properties are provided by more efficient methods.
According to the design thought of the magnesium alloy, an alloy element is expected to be added into magnesium, so that the designed novel magnesium alloy not only has an antibacterial effect through an alkaline environment generated by degradation, but also can release antibacterial metal ions to kill bacteria in the degradation process. Therefore, the sterilization effect of the magnesium alloy can be enhanced, and the antibacterial effect can be continuously exerted by releasing antibacterial metal ions after the alkaline antibacterial effect is weakened or even disappears. Targets were targeted to copper elements by literature review and investigation. Copper has so far been the only solid material that has been registered for U.S. Environmental Protection Agency (EPA) bacteriostasis. Copper can inhibit the growth of pathogenic bacteria for a long time, and copper ions or copper compounds have high-efficiency killing effects on a plurality of bacteria such as staphylococcus aureus, escherichia coli, enterobacter aerogenes, candida albicans, pseudomonas aeruginosa and the like. It can be seen that if the copper element is combined with the magnesium alloy and a certain amount of copper ions are released during the implantation, it is possible to effectively prevent and treat bacterial infection caused by the implant.
Currently, the combination of copper and magnesium is mainly achieved by alloying. Experimental results show that the magnesium-copper alloy can continuously release copper ions to generate an antibacterial effect when being degraded in vivo, overcomes the defect of the antibacterial effect in an alkaline environment, and has remarkable killing effect on staphylococcus aureus, escherichia coli and the like. However, due to the Mg matrix and Mg 2 The strong galvanic corrosion between the Cu second phases causes the magnesium-copper alloy to degrade at an excessive rate, thus greatly limiting the clinical application thereof. Therefore, the alloying means for realizing the combination of magnesium and copper is not an optimal method, and the requirements of clinically matching the degradation rate and the antibacterial property of the implant are difficult to meet.
The copper-containing antibacterial coating is prepared on the surface of the magnesium alloy, so that the problem of galvanic corrosion between copper and a magnesium matrix can be effectively avoided, the coating can also endow the alloy with excellent antibacterial performance through the release of Cu ions while reducing the degradation rate of the magnesium alloy, and the problem of infection caused in the implantation process of the magnesium alloy is solved. At present, few researches are carried out on preparing a copper-containing antibacterial coating on the surface of a magnesium alloy, and the methods of spin coating, film coating, chemical plating, hydrothermal treatment and the like are mainly inquired, but the copper ion release rate of the coating prepared by the method is single, the gradient release of copper ions cannot be realized according to different infection degrees of early postoperative infection, delayed postoperative infection and other stages, the method is prepared by solution media in the atmospheric environment, the pollution and oxidization of a magnesium matrix and a coating material are easily caused, other unnecessary elements are introduced into the surface of the magnesium matrix, and along with the continuous improvement of green environmental protection requirements, the treatment cost of waste liquid is high.
Therefore, there is a need to develop a magnesium alloy surface copper antibacterial coating which is environment-friendly, pollution-free, simple and easy to implement and can change the release amount of copper ions according to the infection degree at different stages after operation.
Disclosure of Invention
The invention provides a method for preparing an antibacterial coating on the surface of magnesium and magnesium alloy, wherein the coating obtained by the method has stable and controllable components, good binding force with a substrate and realizes the gradient release of copper ions according to different infection degrees at different stages such as early infection and delayed infection after operation.
The technical scheme adopted for solving the technical problems is as follows: the method for preparing the antibacterial coating on the surfaces of the magnesium and the magnesium alloy is characterized by comprising the following preparation steps: mounting a copper target at a target position of double-layer glow plasma infiltration plating equipment, fixing a magnesium/magnesium alloy substrate on a sample table of the double-layer glow plasma infiltration plating equipment, arranging the copper target in parallel relative to the magnesium/magnesium alloy substrate, and performing infiltration plating to obtain an infiltration plating layer; the specific diffusion coating parameters are controlled as follows: the source voltage of the copper target is 600-700V, the working voltage of the magnesium/magnesium alloy matrix is 400-450V, the distance between the copper target and the magnesium/magnesium alloy matrix is 8-15 mm, the argon pressure is 20-45 Pa, and the infiltration plating time is 3-5 h.
The main function of the source voltage is to control the ion bombardment energy and density of the source surface, and further control the supply of the alloy element of the source. The higher the source voltage, the higher the ion bombardment energy and ion bombardment density of the source surface, and the larger the alloy element supply amount. The source voltage also has an optimum range, either too high or too low to be good for metal penetration. As the source voltage Vs increases, the ion bombardment density of the source surface increases (the source current Is increases), and the alloy element supply amount M I increases, resulting in an increase in the workpiece surface alloy concentration C, and an increase in the alloy layer thickness. However, vs must not be too high, otherwise, because the supply of the alloy element is too large, a too thick deposition layer is formed on the surface of the workpiece, so that the bombardment effect of ions on the surface of the workpiece is weakened, the diffusion speed of the alloy element is reduced, and the thickness Ld of the diffusion layer is reduced. And controlling the optimal source voltage of the copper target to 600-700V according to the required deposition layer and diffusion layer, wherein both C and Ld are optimal.
The main effect of the workpiece voltage is to heat the workpiece to reach the metal infiltration temperature through the bombardment effect of ions on the surface of the workpiece. The higher the workpiece voltage, the higher the bombardment energy of the ions on the workpiece surface, and the higher the workpiece surface temperature. The workpiece voltage is either too high or too low, which is detrimental to achieving optimal surface alloying penetration. By researching the influence rule of the workpiece voltage when copper is infiltrated on the surface of the magnesium/magnesium alloy, the optimal workpiece voltage is 400-450V. When the workpiece voltage Vc is lower than 400V, the concentration of copper elements in the surface deposition layer is higher, but the ion bombardment energy and the bombardment density on the surface of the workpiece are small, so that the promotion effect on diffusion is small, and the absorption and diffusion of copper elements are not facilitated; when Vc is higher than 450V, ion bombardment on the surface of the workpiece is enhanced, which is favorable for the absorption and diffusion of copper elements, but the back sputtering is enhanced, so that the surface of the workpiece is difficult to keep high-concentration copper elements, and the thickness Ld of a diffusion layer is also reduced; and because the melting point of the magnesium/magnesium alloy is lower, the too high working voltage can lead to the too high surface temperature of the magnesium/magnesium alloy workpiece, so that the magnesium matrix structure is coarse or the material is softened.
The size of the gap between the workpiece and the source should be selected to take into account the spatial transport of the alloying elements. The large polar distance can cause the collision times of the alloy element to be increased and lost in the space transportation process from the source electrode to the workpiece, so that the utilization rate of the alloy element is low, and the formation of a high-concentration alloy permeation layer is not facilitated; the small inter-electrode distance is beneficial to the formation of the high alloy infiltration layer, but when the inter-electrode distance is too small, the tiny change of the inter-electrode distance can have a great influence on the composition and thickness of the alloy infiltration layer. Experimental results show that the optimal distance between the copper target and the magnesium/magnesium alloy matrix is 8-15 mm when copper is plated on the surface of the magnesium/magnesium alloy.
The argon gas pressure directly influences the supply capacity of copper elements and the absorption capacity of a magnesium/magnesium alloy matrix, thereby influencing the formation of an alloy infiltration layer. The gas pressure is too high or too low to facilitate the formation of an optimal alloy deposit. As the gas pressure P increases, the ion bombardment density of the source surface increases, which Is manifested by an increase in the source current Is. The enhancement of the ion bombardment density of the source surface will inevitably lead to an increase in the source sputtering amount, but the back scattering effect is also enhanced due to the rise of the P value, so that a large amount of copper element is returned to the source surface by collision, and finally the source supply MI is reduced. As MI decreases, the workpiece surface alloy concentration C decreases and the diffusion layer thickness Ld decreases. When the P value is low, the free path of gas collision increases, and the ion bombardment energy increases, so that the supply amount of the alloy element is large. However, because the reverse sputtering on the surface of the workpiece is also stronger, the alloy element can be sputtered away again after reaching the surface of the workpiece, and the formation of high-concentration copper ions is not facilitated; in addition, the promotion of diffusion is impaired due to the low ion density of the bombarded surface, which is also detrimental to the formation of thicker alloy strike layers. Experimental results show that the optimal working air pressure is 30-40 Pa, and both C and Ld are optimal.
The time for the diffusion coating is mainly determined by the desired thickness of the diffusion coating. Theoretically, the thickness of the diffusion layer rises in a parabolic manner with the time of diffusion coating, and the thickness of the deposition layer rises in a straight line with the time of diffusion coating. However, in practice, as the time of the diffusion coating is prolonged, the diffusion and diffusion coating speed is also reduced due to the increase of the thickness of the diffusion coating, and the internal stress generated by thickening of the diffusion coating is also unfavorable for the continued increase of the diffusion coating. In addition, when the infiltration plating time is too long, the effect of reverse sputtering can adversely affect the uniform distribution of the infiltration plating elements in the infiltration plating layer. Therefore, according to experimental study results, the infiltration time is preferably 3-5 hours when copper is plated on the surface of the magnesium/magnesium alloy.
Preferably, the diffusion coating layer comprises a deposition layer positioned on the surface of the magnesium/magnesium alloy matrix and a diffusion layer penetrating from the surface of the magnesium/magnesium alloy matrix into the interior; the thickness of the deposition layer is 10-15 mu m, the components are copper and unavoidable impurities, and the microstructure is alpha phase; the thickness of the diffusion layer is 5-12 mu m, and Cu in the diffusion layer forms Mg 2 Cu and Mg 2 The volume fraction of Cu decreases from 2 to 5vol.% to 0 in the surface to interior direction of the magnesium/magnesium alloy matrix. The thickness of the deposition layer and the diffusion layer in this range is optimal, and Mg in the diffusion layer can be realized 2 The gradient distribution of Cu is beneficial to realizing the gradient release of copper ions aiming at different infection degrees of different stages such as early infection and delayed infection after operation.
Preferably, the magnesium alloy is Mg-Sr alloy, mg-Gd alloy or Mg-Dy alloy, wherein the mass percentage content of Mg is more than 95 wt%.
Preferably, the magnesium alloy is Mg-Gd-Dy-Zr alloy, wherein the mass percent of Mg is more than 95 wt%.
Compared with the prior art, the invention has the advantages that: because the double-glow copper plating on the surface of the magnesium/magnesium alloy is a process of adsorption deposition and diffusion, the invention is formed by controlling the source voltage of a copper target of double-layer glow plasma diffusion plating equipment, the working voltage of a magnesium/magnesium alloy matrix, the relative position of a target material and the matrix, the argon gas pressure and the diffusion plating timeDiffusion coating, wherein copper element of the diffusion coating after deposition is diffused into the surface layer of the magnesium/magnesium alloy matrix to form a diffusion layer, and the copper element in the diffusion layer is combined with the magnesium element to form Mg 2 Cu and a magnesium/magnesium alloy matrix belong to metallurgical bonding, gradient release of Cu ions is realized by utilizing different concentrations of Cu ions in each layer, and high-concentration Cu ion release is performed for early infection with stronger postoperative infection degree, so that strong antibacterial treatment is performed; cu ions with continuously reduced concentration are released for the delayed infection with continuously weakened infection degree, and weak antibacterial treatment is carried out, so that the release of Cu ions and the antibacterial function are dynamically matched.
After the surface treatment of magnesium and magnesium alloy by adopting the preparation method provided by the invention, the corrosion rate is below 0.2mm/year, the cytotoxicity rating is 0 level, and the method has no cytotoxicity.
Detailed Description
The present invention is described in further detail below with reference to examples.
Example 1
1) A40X 25X 3mm copper (Cu) target was prepared by electromagnetic vacuum melting.
2) Copper (Cu) targets are arranged at the target positions of double-layer glow plasma infiltration plating equipment, and sand paper with different roughness is adopted for the copper (Cu) targetsThe surface of the Mg-Sr (the mass percentage content of Mg is 97 wt%) alloy is polished to 2000#, then horizontally fixed on a sample table of double-layer glow plasma diffusion plating equipment and positioned right below a copper (Cu) target, and the copper target is arranged in parallel relative to the Mg-Sr alloy, so that the relative position of the Mg-Sr alloy and the target is kept unchanged. The copper (Cu) target is connected to a radio frequency power supply, and the source voltage is 700V. The Mg-Sr alloy matrix is connected with a direct current power supply, the working voltage is 420V, and the distance between a copper (Cu) target and the Mg-Sr alloy matrix is 10mm. In the whole preparation process, the argon pressure is 40Pa, the working time is 3 hours, and finally the infiltration layer with a deposition layer and a diffusion layer is obtained.
The components of the deposition layer are copper and unavoidable impurities, and the microstructure is alpha phase; cu in diffusion layer forms Mg 2 Cu and Mg 2 Volume fraction of Cu along Mg-Sr matrix tableThe face-to-interior direction is continually reduced from 3vol.% to 0.
Example 2:
1) A copper (Cu) target of 40X 3mm was prepared by using spherical copper powder with a diameter of 13-53 μm using a laser selective melting 3D printing technique.
2) Mounting 40×40×3mm copper (Cu) target material in double-layer glow plasma infiltration plating equipment, and adopting sand paper with different roughness to implement the methodThe surface of the Mg-Gd-Dy-Zr alloy is polished to 2000# and then horizontally fixed on a sample table of double-layer glow plasma diffusion plating equipment, and the surface is positioned right below a copper (Cu) target, the copper target is arranged in parallel relative to the Mg-Gd-Dy-Zr alloy, and the relative position of the Mg-Gd-Dy-Zr alloy and the target is kept unchanged. The copper (Cu) target is connected to a radio frequency power supply, and the source voltage is 680V. The Mg-Gd-Dy-Zr alloy matrix is connected with a direct current power supply, the working voltage is 450V, and the distance between a copper (Cu) target and the matrix is 8mm. In the whole preparation process, the argon pressure is 40Pa, the working time is 5 hours, and finally the infiltration layer with a deposition layer and a diffusion layer is obtained.
The components of the deposition layer are copper and unavoidable impurities, and the microstructure is alpha phase; cu in diffusion layer forms Mg 2 Cu and Mg 2 The volume fraction of Cu decreases from 3.5vol.% to 0 in the direction from the surface to the interior of the Mg-Gd-Dy-Zr matrix.
Example 3
1) A copper (Cu) target of 20X 60X 3mm was prepared by electromagnetic vacuum melting.
2) Copper (Cu) targets are arranged at the target positions of the arc glow plasma infiltration plating equipment, and sand paper with different roughness is adopted to carry out the processThe surface of the Mg (99.994 wt.%) block is polished to 2000#, then horizontally fixed on a sample table of a double-layer glow plasma diffusion plating device and positioned right below a copper (Cu) target, and the copper target is arranged in parallel relative to the Mg block, so that the relative position of the Mg block and the target is kept unchanged. Copper (Cu) target is connected to radio frequency power supplyThe source voltage is 600V. The Mg block is connected with a direct current power supply, the working voltage is 400V, and the distance between a copper (Cu) target and the Mg block is 8mm. In the whole preparation process, the argon pressure is 30Pa, the working time is 4 hours, the treatment temperature is 480 ℃, and finally the infiltration layer with a deposition layer and a diffusion layer is obtained.
The components of the deposition layer are copper and unavoidable impurities, and the microstructure is alpha phase; cu in diffusion layer forms Mg 2 Cu and Mg 2 The volume fraction of Cu decreases from 4vol.% to 0 in the direction from the magnesium base surface to the inside.
Comparative example:
1) Surface treatment: sandpaper with different roughnessThe surface of the sample was polished to 2000#, polished with 3.5 μm diamond gypsum, then degreased with absolute ethanol in an ultrasonic bath for 15 minutes, and then dried at room temperature for later use;
2) Preparing copper-containing composite sol: 7.5wt% PCL with the molecular weight of 70000-90000g/mol is dissolved in chloroform, and bioactive glass (2 wt% Cu-BGN) containing 2wt% nanometer copper powder is mixed with the solution to prepare copper-containing composite sol;
3) Spin coating of magnesium samples: a sample tray of 25X 25mm is selected, a magnesium sample is placed on a sample stage of a spin coater, 300 microliter of sol is dripped in the center of the magnesium sample by using a microsyringe, the sol is pre-rotated for 10s at a speed of 500 revolutions per minute, after the sol spreads on the surface of the sample, the sol is rotated for 30s at a speed of 3000 revolutions per minute, and the spin-coated sample is placed in a vacuum drying box and dried in vacuum at normal temperature for 24h.
The resulting 3 examples were tested for deposited and diffused layer thickness and the specific results are shown in table 1.
The resulting 3 and 1 comparative examples were subjected to corrosion performance test, cytotoxicity rating, cytotoxicity evaluation, and specific results are shown in table 1.
The detection method of the deposition layer and the diffusion layer comprises the following steps: and (3) polishing the section of the sample prepared by the surface coating to 2000#, polishing, placing under a scanning electron microscope, and adopting secondary electron observation and measurement to obtain the product.
Corrosion performance test: and (3) washing and drying the tablet sample with the diameter of phi 10mm multiplied by 3mm after the surface coating preparation by alcohol. 3 in parallel. Before the start of the experiment, all sample weights were measured and recorded using an electronic microbalance, then the samples were placed in clean 15mL centrifuge tubes, fresh Hank's solution was added to each centrifuge tube in a ratio of sample surface area (cm 2) to Hank's solution volume (mL) of 1.25cm2/mL (solution formulation as in table 2, pH adjusted to 7.4 after formulation), and then placed in an incubator at 37±0.5 ℃ with the soak solution changed once per day. After soaking for 30 days, the soaked sample was taken out and the surface was dried with a blower, a macroscopic photograph of the corroded sample was taken, then each was ultrasonically cleaned sequentially with chromic acid solution (200 g/L), distilled water, and alcohol for 10 minutes, and the blower was dried and weighed to calculate the average corrosion rate. The average corrosion rate was calculated as:
Corrosion rate=(K×W)/(A×T×D)
wherein: k=8.76×104; w is the difference in sample weight (g) before and after soaking; a is the surface area (cm 2) of the sample exposed to Hank's solution during soaking; t is the sample soaking time (h); d is the material density (g/cm 3).
Cytotoxicity ranking method: 1) Preparing a material leaching solution: cytotoxicity ratings in the present invention were tested using the leaching solution method. Test samples were immersed in 15mL centrifuge tubes containing serum-free alpha-MEM medium (Hyclone, USA) and endothelial cell medium Sciencell, USA, respectively, at a ratio of 1.25cm2/mL sample surface area to volume, and incubated in a sterile incubator at 37.+ -. 0.5 ℃ for 24h according to ISO10993-5 standard. After the soaking, carefully taking out the sample in the tube by using forceps, discarding the sample, centrifuging the rest soaking liquid in a centrifuge at 5000r/min for 5min, taking supernatant, filtering by using a 0.22 mu m pillow filter, and placing the filtered leaching liquid in a sterile tube for standby at 4 ℃. 2) Cytotoxicity test: the preosteoblasts MC3T3-E1 of the rats in logarithmic growth phase after passaging were carefully washed three times with sterile PBS solution, and after 2min of digestion with 0.25% trypsin, the cells were collected and centrifuged, and counted by a counting plate. At 5X 10 3 cell density of cells/100mL was inoculated in sterile 96In the well plate, 100 μl of each well, 6 wells were multiplexed. To ensure that the results were accurate and the humidity of the surrounding environment was sufficient, the cells were not seeded in the very edge of the 96-well plate, but sterile PBS solution (solution formulation shown in Table 3) was added. Put in 5% CO 2 Culturing in a cell incubator at 37+ -0.5deg.C for 24h for cell attachment. At this time, the absorbance of each well of the 96-well plate is tested by an enzyme-labeled instrument, and whether the values are close or not is observed so as to ensure that the cell number of each well is not different and is in the same standard before the material leaching liquid is added. After careful pipetting of the cell culture broth from each well, PBS was used for washing, and 100. Mu.L of material extract and 10% fetal bovine serum were added to each well and incubated with cells for 1 day. After the time point, the material extract in the wells was discarded, 5mg/mL MTT was added, 100. Mu.L per well, incubation was continued in the cell incubator for 4 hours, then 150. Mu.L of dimethyl sulfoxide (DMSO) was added per well with careful pipetting, and the mixture was left on a shaker at room temperature with gentle shaking for 15min to allow complete dissolution. The absorbance (OD) of each well was measured with an enzyme-labeled instrument and the value was recorded, the measurement wavelength was 490nm, and the reference wavelength was 570nm. The effect of the magnesium-strontium alloy on the cell proliferation rate was evaluated by the change of the OD value after 1 day of culture. And calculating the relative proliferation rate of the cells according to the OD value result: relative Cell Growth Rate% (RCGR) =od experimental group/OD negative control x 100%, where the negative control was PBS solution wells. The experiment was repeated three times.
According to RGR value, evaluating cytotoxicity by referring to ISO10993-5 in vitro cytotoxicity test, wherein the evaluation standard is (1) RGR value is not less than 100%, cytotoxicity grade is 0 grade, and the product is qualified; (2) RGR value is more than or equal to 80%, cytotoxicity grade is grade 1, and the product is qualified; (2) RGR value is 50% -80%, cytotoxicity grade is grade 2, should combine the comprehensive evaluation of cell morphology; RGR value is less than or equal to 49%, cytotoxicity grade is 3-4, and the product is unqualified. TABLE 1 parameter control and Performance test results for the diffusion coatings of examples and comparative examples of the present invention
TABLE 2 Hank's solution composition for corrosion performance testing in the present invention
Composition of the components | Concentration, g/L |
NaCl | 8.00 |
KCl | 0.40 |
CaCl 2 | 0.14 |
NaHCO 3 | 0.35 |
Na 2 HPO 4 | 0.12 |
MgSO 4 | 0.20 |
KH 2 PO 4 | 0.06 |
Glucose | 1.00 |
TABLE 3 PBS solution Components used in cytotoxicity experiments in the present invention
Composition of the components | Concentration, g/L |
NaCl | 8.00 |
KCl | 0.20 |
Na 2 HPO 4 | 2.89 |
KH 2 PO 4 | 0.20 |
Claims (3)
1. The method for preparing the antibacterial coating on the surfaces of the magnesium and the magnesium alloy is characterized by comprising the following preparation steps: mounting a copper target at a target position of double-layer glow plasma infiltration plating equipment, fixing a magnesium/magnesium alloy substrate on a sample table of the double-layer glow plasma infiltration plating equipment, arranging the copper target in parallel relative to the magnesium/magnesium alloy substrate, and performing infiltration plating to obtain an infiltration plating layer; the specific diffusion coating parameters are controlled as follows: the source voltage of the copper target is 600-700V, the working voltage of the magnesium/magnesium alloy matrix is 400-450V, the distance between the copper target and the magnesium/magnesium alloy matrix is 8-15 mm, the argon pressure is 20-45 Pa, and the infiltration plating time is 3-5 h; the diffusion coating comprises a deposition layer positioned on the surface of the magnesium/magnesium alloy matrix and a diffusion layer penetrating into the magnesium/magnesium alloy matrix from the surface of the magnesium/magnesium alloy matrix; the thickness of the deposition layer is 10-15 mu m, the components are copper and unavoidable impurities, and the microstructure is alpha phase; the thickness of the diffusion layer is 5-12 mu m, and Cu in the diffusion layer forms Mg 2 Cu and Mg 2 The volume fraction of Cu is from the surface to the inside of the magnesium/magnesium alloy matrix2 to 5vol.% is continuously reduced to 0.
2. The method for preparing the antibacterial coating on the surface of the magnesium and magnesium alloy according to claim 1, wherein the method comprises the following steps: the magnesium alloy is Mg-Sr alloy, mg-Gd alloy or Mg-Dy alloy, wherein the mass percentage content of Mg is more than 95 percent.
3. The method for preparing the antibacterial coating on the surface of the magnesium and magnesium alloy according to claim 1, wherein the method comprises the following steps: the magnesium alloy is Mg-Gd-Dy-Zr alloy, wherein the mass percentage content of Mg is more than 95 wt%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111563708.4A CN114369808B (en) | 2021-12-20 | 2021-12-20 | Method for preparing antibacterial coating on surface of magnesium and magnesium alloy |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111563708.4A CN114369808B (en) | 2021-12-20 | 2021-12-20 | Method for preparing antibacterial coating on surface of magnesium and magnesium alloy |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114369808A CN114369808A (en) | 2022-04-19 |
CN114369808B true CN114369808B (en) | 2024-02-06 |
Family
ID=81141133
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111563708.4A Active CN114369808B (en) | 2021-12-20 | 2021-12-20 | Method for preparing antibacterial coating on surface of magnesium and magnesium alloy |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114369808B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116328025B (en) * | 2023-05-29 | 2023-08-08 | 北京大学第三医院(北京大学第三临床医学院) | Medical implant material, implant and preparation method thereof |
Citations (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1793428A (en) * | 2005-12-31 | 2006-06-28 | 武汉科技大学 | Process for preparing anti-bacteria stainless steel by double-layer glowing method |
CN101008078A (en) * | 2007-01-30 | 2007-08-01 | 南京航空航天大学 | Method for precipitating large area amorphous, nanocrystalline alloy layer using magnesium alloy surface glow plasma |
WO2008028355A1 (en) * | 2006-08-28 | 2008-03-13 | Peiqi Jiang | Method for making surface antibacterial products utilizing physical vapor deposition technology |
CN101156575A (en) * | 2007-08-27 | 2008-04-09 | 张涛 | metal basis antibiotic paster and technics for preparing preformation corpora using magnetron sputtering method |
CN101302606A (en) * | 2007-05-11 | 2008-11-12 | 北京石油化工学院 | Magnesium alloy surface strengthening method and apparatus |
CN101476108A (en) * | 2007-12-31 | 2009-07-08 | 比亚迪股份有限公司 | Magnesium alloy composite material and preparation thereof |
CN102703864A (en) * | 2012-05-31 | 2012-10-03 | 太原理工大学 | Method for performing arc-added glow discharge ion diffusion coating on magnesium alloy plate |
CN102886071A (en) * | 2011-07-20 | 2013-01-23 | 上海纳米技术及应用国家工程研究中心有限公司 | Medicinal silver-loaded metal bioactive coating as well as preparation method and application thereof |
CN103088285A (en) * | 2013-01-15 | 2013-05-08 | 太原理工大学 | Preparation method of nickel-copper alloy depositing layer |
CN104630895A (en) * | 2014-12-30 | 2015-05-20 | 中国兵器科学研究院宁波分院 | Single-crystal magnesium alloy biodegradable material and preparation method thereof |
WO2015074354A1 (en) * | 2013-11-21 | 2015-05-28 | 东莞宜安科技股份有限公司 | New biodegradable magnesium-based alloy with antibacterial function |
CN104762542A (en) * | 2015-03-26 | 2015-07-08 | 中国科学院金属研究所 | Biomedical degradable absorption Mg-Sr-Cu alloy material, preparation method and application |
WO2016080937A1 (en) * | 2014-11-17 | 2016-05-26 | Dopa Ilac San. Tic. Ltd Sti. | Antibacterial osseoconductive thin film for implant |
CN107119260A (en) * | 2016-02-24 | 2017-09-01 | 中国科学院金属研究所 | A kind of bone implantation magnesium-copper coating and preparation method thereof |
CN107354444A (en) * | 2017-07-18 | 2017-11-17 | 太原理工大学 | A kind of method for improving magnesium based metal corrosion resistance and wearability |
CN107419233A (en) * | 2017-06-26 | 2017-12-01 | 南京航空航天大学 | A kind of titanium aluminium base alloy surface protection coating and preparation method thereof |
CN107653410A (en) * | 2017-09-15 | 2018-02-02 | 中国兵器科学研究院宁波分院 | Magnesium alloy that biological medical degradable absorbs and its preparation method and application |
CN108379658A (en) * | 2018-02-06 | 2018-08-10 | 中国科学院金属研究所 | With the orthopaedics implant devices and preparation method thereof containing copper coating |
CN108411274A (en) * | 2018-04-27 | 2018-08-17 | 天津大学 | The preparation method of the pulse laser Plasma inpouring of Mg/Zn graded alloy |
CN108939155A (en) * | 2017-05-17 | 2018-12-07 | 上海交通大学 | A kind of magnesium-based tissue engineering material antimicrobial coating and preparation method thereof |
CN109652767A (en) * | 2017-10-10 | 2019-04-19 | 中国科学院金属研究所 | A kind of zinc-silver-copper coating and preparation method thereof |
CN109652766A (en) * | 2017-10-10 | 2019-04-19 | 中国科学院金属研究所 | A kind of medical embedded material magnesium-silver-copper coating and preparation method thereof |
CN109652769A (en) * | 2017-10-10 | 2019-04-19 | 中国科学院金属研究所 | A kind of medical embedded material magnesium-silver coating and preparation method thereof |
CN110408894A (en) * | 2019-07-23 | 2019-11-05 | 同济大学 | A kind of Ti-Mg alloy coat and the preparation method and application thereof |
CN110965024A (en) * | 2019-10-29 | 2020-04-07 | 南京航空航天大学 | Biomedical material and preparation method thereof |
CN111455317A (en) * | 2020-05-18 | 2020-07-28 | 东莞立德生物医疗有限公司 | Degradable magnesium alloy coated bone nail and preparation method thereof |
CN111481739A (en) * | 2020-05-18 | 2020-08-04 | 东莞立德生物医疗有限公司 | Biomedical degradable magnesium alloy material and preparation method thereof |
CN111500889A (en) * | 2020-05-18 | 2020-08-07 | 东莞立德生物医疗有限公司 | Degradable magnesium alloy coated bone nail and preparation method thereof |
CN111876645A (en) * | 2020-07-13 | 2020-11-03 | 中国兵器科学研究院宁波分院 | Ta-W-Nb-Al-Cr-Ti-Si series high-entropy alloy infiltration coating for high-flux screening and preparation method thereof |
CN112076348A (en) * | 2020-07-22 | 2020-12-15 | 浙江大学 | Medical metal surface anti-infection and osseointegration promotion coating, preparation method and application |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE20020649U1 (en) * | 2000-12-06 | 2002-04-11 | stryker Trauma GmbH, 24232 Schönkirchen | Device for surgical or therapeutic use, in particular implants and surgical instruments and their accessories |
CN102886926A (en) * | 2011-07-20 | 2013-01-23 | 鸿富锦精密工业(深圳)有限公司 | Antibacterial film coated piece and preparation method thereof |
CA2906419C (en) * | 2013-03-14 | 2021-07-06 | DePuy Synthes Products, Inc. | Magnesium alloy with adjustable degradation rate |
WO2018067086A2 (en) * | 2016-08-12 | 2018-04-12 | Istanbul Teknik Universitesi | Production method of a thick coating with layered structure |
CN109487214A (en) * | 2018-12-21 | 2019-03-19 | 昆山英利悦电子有限公司 | A kind of magnesium-alloy surface coating method and Corrosion-resistant magnesia alloy prepared therefrom |
-
2021
- 2021-12-20 CN CN202111563708.4A patent/CN114369808B/en active Active
Patent Citations (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1793428A (en) * | 2005-12-31 | 2006-06-28 | 武汉科技大学 | Process for preparing anti-bacteria stainless steel by double-layer glowing method |
WO2008028355A1 (en) * | 2006-08-28 | 2008-03-13 | Peiqi Jiang | Method for making surface antibacterial products utilizing physical vapor deposition technology |
CN101008078A (en) * | 2007-01-30 | 2007-08-01 | 南京航空航天大学 | Method for precipitating large area amorphous, nanocrystalline alloy layer using magnesium alloy surface glow plasma |
CN101302606A (en) * | 2007-05-11 | 2008-11-12 | 北京石油化工学院 | Magnesium alloy surface strengthening method and apparatus |
CN101156575A (en) * | 2007-08-27 | 2008-04-09 | 张涛 | metal basis antibiotic paster and technics for preparing preformation corpora using magnetron sputtering method |
CN101476108A (en) * | 2007-12-31 | 2009-07-08 | 比亚迪股份有限公司 | Magnesium alloy composite material and preparation thereof |
CN102886071A (en) * | 2011-07-20 | 2013-01-23 | 上海纳米技术及应用国家工程研究中心有限公司 | Medicinal silver-loaded metal bioactive coating as well as preparation method and application thereof |
CN102703864A (en) * | 2012-05-31 | 2012-10-03 | 太原理工大学 | Method for performing arc-added glow discharge ion diffusion coating on magnesium alloy plate |
CN103088285A (en) * | 2013-01-15 | 2013-05-08 | 太原理工大学 | Preparation method of nickel-copper alloy depositing layer |
WO2015074354A1 (en) * | 2013-11-21 | 2015-05-28 | 东莞宜安科技股份有限公司 | New biodegradable magnesium-based alloy with antibacterial function |
WO2016080937A1 (en) * | 2014-11-17 | 2016-05-26 | Dopa Ilac San. Tic. Ltd Sti. | Antibacterial osseoconductive thin film for implant |
CN104630895A (en) * | 2014-12-30 | 2015-05-20 | 中国兵器科学研究院宁波分院 | Single-crystal magnesium alloy biodegradable material and preparation method thereof |
CN104762542A (en) * | 2015-03-26 | 2015-07-08 | 中国科学院金属研究所 | Biomedical degradable absorption Mg-Sr-Cu alloy material, preparation method and application |
CN107119260A (en) * | 2016-02-24 | 2017-09-01 | 中国科学院金属研究所 | A kind of bone implantation magnesium-copper coating and preparation method thereof |
CN108939155A (en) * | 2017-05-17 | 2018-12-07 | 上海交通大学 | A kind of magnesium-based tissue engineering material antimicrobial coating and preparation method thereof |
CN107419233A (en) * | 2017-06-26 | 2017-12-01 | 南京航空航天大学 | A kind of titanium aluminium base alloy surface protection coating and preparation method thereof |
CN107354444A (en) * | 2017-07-18 | 2017-11-17 | 太原理工大学 | A kind of method for improving magnesium based metal corrosion resistance and wearability |
CN107653410A (en) * | 2017-09-15 | 2018-02-02 | 中国兵器科学研究院宁波分院 | Magnesium alloy that biological medical degradable absorbs and its preparation method and application |
CN109652767A (en) * | 2017-10-10 | 2019-04-19 | 中国科学院金属研究所 | A kind of zinc-silver-copper coating and preparation method thereof |
CN109652766A (en) * | 2017-10-10 | 2019-04-19 | 中国科学院金属研究所 | A kind of medical embedded material magnesium-silver-copper coating and preparation method thereof |
CN109652769A (en) * | 2017-10-10 | 2019-04-19 | 中国科学院金属研究所 | A kind of medical embedded material magnesium-silver coating and preparation method thereof |
CN108379658A (en) * | 2018-02-06 | 2018-08-10 | 中国科学院金属研究所 | With the orthopaedics implant devices and preparation method thereof containing copper coating |
CN108411274A (en) * | 2018-04-27 | 2018-08-17 | 天津大学 | The preparation method of the pulse laser Plasma inpouring of Mg/Zn graded alloy |
CN110408894A (en) * | 2019-07-23 | 2019-11-05 | 同济大学 | A kind of Ti-Mg alloy coat and the preparation method and application thereof |
CN110965024A (en) * | 2019-10-29 | 2020-04-07 | 南京航空航天大学 | Biomedical material and preparation method thereof |
CN111455317A (en) * | 2020-05-18 | 2020-07-28 | 东莞立德生物医疗有限公司 | Degradable magnesium alloy coated bone nail and preparation method thereof |
CN111481739A (en) * | 2020-05-18 | 2020-08-04 | 东莞立德生物医疗有限公司 | Biomedical degradable magnesium alloy material and preparation method thereof |
CN111500889A (en) * | 2020-05-18 | 2020-08-07 | 东莞立德生物医疗有限公司 | Degradable magnesium alloy coated bone nail and preparation method thereof |
CN111876645A (en) * | 2020-07-13 | 2020-11-03 | 中国兵器科学研究院宁波分院 | Ta-W-Nb-Al-Cr-Ti-Si series high-entropy alloy infiltration coating for high-flux screening and preparation method thereof |
CN112076348A (en) * | 2020-07-22 | 2020-12-15 | 浙江大学 | Medical metal surface anti-infection and osseointegration promotion coating, preparation method and application |
Non-Patent Citations (7)
Title |
---|
Biodegradable Mg-Cu alloys with enhanced osteogenesis, angiogenesis, and long-lasting antibacterial effects;Chen Liu;Scientific reports;全文 * |
刘阳 ; 徐晋勇 ; 高波 ; 高成 ; .等离子体表面技术制备抗菌不锈钢的研究进展.机械工程材料.2018,(第09期), * |
抗菌医用金属材料的研究与发展;任玲;杨春光;杨柯;;中国医疗设备(第01期);全文 * |
植入体内新型镁合金材料的抗菌性能;王湛;中国组织工程研究;第22卷;全文 * |
等离子体表面技术制备抗菌不锈钢的研究进展;刘阳;徐晋勇;高波;高成;;机械工程材料(第09期) * |
等离子表面合金化制备抗菌不锈钢及其组织与性能;蒋立;张翔宇;黄晓波;张敏;唐宾;;机械工程材料(第11期) * |
蒋立 ; 张翔宇 ; 黄晓波 ; 张敏 ; 唐宾 ; .等离子表面合金化制备抗菌不锈钢及其组织与性能.机械工程材料.2012,(第11期), * |
Also Published As
Publication number | Publication date |
---|---|
CN114369808A (en) | 2022-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhang et al. | Antibacterial ability and cytocompatibility of Cu-incorporated Ni–Ti–O nanopores on NiTi alloy | |
Sedelnikova et al. | Zn-, Cu-or Ag-incorporated micro-arc coatings on titanium alloys: Properties and behavior in synthetic biological media | |
Chang et al. | Antibacterial properties and cytocompatibility of tantalum oxide coatings | |
Gao et al. | Fabrication and characterization of bioactive composite coatings on Mg–Zn–Ca alloy by MAO/sol–gel | |
Rajan et al. | A comprehensive review on biocompatible thin films for biomedical application | |
CN107456610B (en) | Zn-Ag series zinc alloy and preparation method and application thereof | |
Lin et al. | A surface-engineered multifunctional TiO2 based nano-layer simultaneously elevates the corrosion resistance, osteoconductivity and antimicrobial property of a magnesium alloy | |
Han et al. | Mg/Ag ratios induced in vitro cell adhesion and preliminary antibacterial properties of TiN on medical Ti-6Al-4V alloy by Mg and Ag implantation | |
Song et al. | Antibacterial properties and biocompatibility in vivo and vitro of composite coating of pure magnesium ultrasonic micro-arc oxidation phytic acid copper loaded | |
CN107829123B (en) | Aluminum alloy with double-layer coating on surface and preparation method and application thereof | |
CN111334688A (en) | Zn-RE series zinc alloy and preparation method and application thereof | |
CN114369808B (en) | Method for preparing antibacterial coating on surface of magnesium and magnesium alloy | |
CN102886071A (en) | Medicinal silver-loaded metal bioactive coating as well as preparation method and application thereof | |
Chu et al. | Surface design of biodegradable magnesium alloys for biomedical applications | |
Lu et al. | Nanostructured Cu-doped TiO2 with photothermal effect for prevention of implant-associated infection | |
Tolde et al. | Growth of a TiNb adhesion interlayer for bioactive coatings | |
Cheng et al. | An in vitro and in vivo comparison of Mg (OH) 2-, MgF 2-and HA-coated Mg in degradation and osteointegration | |
Lenis et al. | Multi-layer bactericidal silver-calcium phosphate coatings obtained by RF magnetron sputtering | |
Song et al. | Controllable Ag/Ta ratios of co-implanted TiN films on titanium alloys for osteogenic enhancement and antibacterial responses | |
Xiao et al. | Investigation of zinc-silver alloys as biodegradable metals for orthopedic applications | |
Chen et al. | In vitro and in vivo studies on the biodegradable behavior and bone response of Mg69Zn27Ca4 metal glass for treatment of bone defect | |
Qiao et al. | Effect of trace copper on the microstructure, corrosion behavior and biological properties of biodegradable Mg–2Zn-1Gd-0.5 Zr alloy | |
Chen et al. | Degradation behavior, biocompatibility and antibacterial activity of plasma electrolytic oxidation treated zinc substrates | |
Ibrahim et al. | Fabrication of biodegradable MgXCu (X= 0, 0.1, 0.4, 0.7) coating on Ti6Al4V alloy with enhanced antibacterial property | |
Ozeki et al. | Antibacterial effect of Ag-containing hydroxyapatite thin film fabricated by sputtering |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |